HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sanfilippo D syndrome: estimation of N-acetylglucosamine-6-sulfatase activity with a radiolabeled monosulfated disaccharide substrate.

Abstract
N-Acetylglucosamine-6-sulfatase activity was assayed by incubation of the radiolabeled disaccharide O-(a-N-acetylglucosamine-6-sulfate)-(1----3)-L-[6-3H]-idonic acid (GlcNAc6S-IdOA), with homogenates of leucocytes, cultured fibroblasts, and urine from normal individuals, patients affected with N-acetylglucosamine-6-sulfatase-deficiency (Sanfilippo D syndrome, mucopolysaccharidosis type IIID), and patients affected with other mucopolysaccharidoses and lysosomal storage disorders. The assay clearly distinguished affected homozygotes from their obligate heterozygotes and normal controls and other lysosomal storage disorders. Sulfatase activity in fibroblasts, leucocytes, and urine toward GlcNAc6S-IdOA exhibited a pH optimum at 4.2, 4.5, and 5.1, respectively. Sulfatase activity in fibroblasts had an apparent Km of 7.2 microM and was significantly inhibited by both sulfate and phosphate ions. The action of fibroblast or leucocyte N-acetylglucosamine-6-sulfatase activity toward GlcNAc6S-IdOA is recommended for the routine enzymatic detection and classification of mucopolysaccharidosis type IIID patients.
AuthorsC Freeman, J J Hopwood
JournalAnalytical biochemistry (Anal Biochem) Vol. 176 Issue 2 Pg. 244-8 (Feb 01 1989) ISSN: 0003-2697 [Print] United States
PMID2500866 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Disaccharides
  • Tritium
  • O-((Nalpha)-acetylglucosamine 6-sulfate)-(1-3)-idonic acid
  • Sulfatases
  • N-acetylglucosamine-6-sulfatase
Topics
  • Amnion (enzymology)
  • Chorionic Villi (enzymology)
  • Disaccharides
  • Fibroblasts (enzymology)
  • Humans
  • Leukocytes (enzymology)
  • Mucopolysaccharidoses (diagnosis)
  • Mucopolysaccharidosis III (diagnosis)
  • Skin (enzymology)
  • Substrate Specificity
  • Sulfatases (analysis)
  • Tritium

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: